VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $197.20)
- $197.20 P/E (TTM): 21.33X Cap: $389M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $175.16)
- $175.16 P/E (TTM): 21.3X Cap: $8.75B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $49.81)
- $49.81 Cap: $19.45B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $197.20)
- $197.20 P/E (TTM): 21.33X Cap: $389M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $175.16)
- $175.16 P/E (TTM): 21.3X Cap: $8.75B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $54.73)
- $54.73 Cap: $5.21B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $197.20)
- $197.20 P/E (TTM): 21.33X Cap: $389M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $749.33)
- $749.33 P/E (TTM): 17.55X Cap: $78.75B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $218.01)
- $218.01 P/E (TTM): 21.06X Cap: $525.25B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,078.52)
- $1,078.52 P/E (TTM): 50.94X Cap: $1.01T
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $111.11)
- $111.11 P/E (TTM): 14.47X Cap: $275.77B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $25.89)
- $25.89 P/E (TTM): 14.84X Cap: $147.20B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $636.30)
- $636.30 P/E (TTM): 35.76X Cap: $239.06B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $59.32)
- $59.32 P/E (TTM): 17.24X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $175.16)
- $175.16 P/E (TTM): 21.3X Cap: $8.75B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $49.81)
- $49.81 Cap: $19.45B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $197.20)
- $197.20 P/E (TTM): 21.33X Cap: $389M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $87.10)
- $87.10 P/E (TTM): 22.53X Cap: $955M
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023